Association between Chinese visceral adiposity index and lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH): a national cohort study
K M Chang,
No information about this author
Bo Li,
No information about this author
Gang Wang
No information about this author
et al.
BMC Urology,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: Jan. 23, 2025
Benign
prostatic
hyperplasia
(BPH)
and
its
related
lower
urinary
tract
symptoms
(LUTS)
are
commonly
observed
among
aging
males
have
a
substantial
effect
on
quality
of
life.
Metabolic
syndrome,
with
specific
focus
obesity,
is
believed
to
play
role
in
the
development
BPH.
This
study
intends
explore
relationship
between
several
obesity-related
metrics,
including
Chinese
Visceral
Adiposity
Index
(CVAI),
LUTS/BPH
within
national
cohort
men.
Data
from
China
Health
Retirement
Longitudinal
Study
(CHARLS)
2015
were
analyzed,
encompassing
sample
5,735
male
participants
aged
45
older.
Eight
indices—namely
Body
mass
index
(BMI),
Waist-height
ratio
(WHtR),
Triglyceride-glucose.BMI
(TyG.BMI),
TyG.
Waist
circumference
(TyG.WC),
TyG.WHtR,
CVAI,
adiposity
(VAI),
A
body
shape
(ABSI)—were
examined.
Logistic
regression
models,
adjusted
for
potential
confounders,
utilized
evaluate
associations
these
indices
LUTS
or
The
predictive
capabilities
further
assessed
using
receiver
operating
curves
(ROC).
Among
participants,
718
(12.5%)
diagnosed
LUTS/BPH.
All
significantly
higher
group
compared
healthy
group.
CVAI
demonstrated
highest
ability
LUTS/BPH,
an
area
under
curve
(AUC)
0.58.
highlighted
nonlinear
indices,
CVAI.
underscores
significant
association
visceral
fat,
as
measured
by
risk
emerged
most
effective
predictor
evaluated,
suggesting
utility
identifying
individuals
at
Further
prospective
studies
needed
confirm
findings
elucidate
underlying
mechanisms.
Language: Английский
Evaluation of the therapeutic potential of Garcinia cambogia alone or in combination with Silodosin in the management of LUTS/BPH: A prospective randomized controlled study
Urology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 1, 2025
Language: Английский
Metabolic insights into hypoxia adaptation in adolescent athletes at different altitudes: a cross-sectional study
Frontiers in Molecular Biosciences,
Journal Year:
2025,
Volume and Issue:
12
Published: May 9, 2025
Athletes
use
hypoxic
training
methods
to
enhance
their
performance
under
altitude
conditions.
Comparative
studies
involving
populations
from
low
(500–2,000
m)
and
moderate
(2,000–3,000
altitudes
offer
an
opportunity
understand
the
mechanisms
behind
adaptations
hypoxia.
The
present
study
combined
data
metabolomics
analysis
based
on
gas-
liquid-chromatography
mass
spectrometry
(GC-MS
LC-MS)
compare
plasma
profiles
80
adolescent
athletes
at
moderate-
or
altitudes.
161
metabolites
were
identified,
including
84
elevated
77
decreased
in
moderate-altitude
adolescents
compared
low-altitude
counterparts.
Pathway
revealed
that
related
carbohydrates,
amino
acids,
lipid
metabolism
differed
between
groups.
Lipid
was
significantly
altered
athletes,
pathways
such
as
linolenic
linoleic
acid,
sphingolipid,
arachidonic
well
processes
transfer
of
acetyl
groups
into
mitochondria
fatty
acid
biosynthesis.
Biomarker
looking
for
signatures
chronic
adaptation
identified
glycerol
5-oxoproline
amongst
variables
with
strongest
sensitivity
specificity.
This
demonstrates
differences
metabolic
highlights
potential
these
differential
associated
provide
new
insights
altitude.
Language: Английский
Plasma metabolites as mediators in the relationship between inflammation-related proteins and benign prostatic hyperplasia: insights from mendelian randomization
Yan Cui,
No information about this author
Hui Wang,
No information about this author
Y Wang
No information about this author
et al.
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: Oct. 30, 2024
Benign
prostatic
hyperplasia
(BPH)
is
a
condition
commonly
observed
in
aging
males.
Inflammatory
and
metabolic
factors
are
pivotal
the
development
progression
of
BPH.
The
degree
to
which
effects
91
inflammation-related
proteins
on
BPH
mediated
by
1400
plasma
metabolites
remains
ambiguous.
Our
research
analyzed
impact
these
traits
utilizing
genetic
evidence.Two-sample
Mendelian
randomization
(MR)
multivariable
MR
(MVMR)
were
utilized
our
study
infer
causal
effect
BPH,
with
serving
as
mediators.
Increased
levels
IL-2
linked
heightened
incidence
(β
=
0.071,
OR:1.074,
95%
CI
[1.002-1.152],
p
0.045),
whereas
lower
concentrations
N6,N6-dimethyllysine
associated
decreased
risk
(β1=-0.127,
0.02;
β2=-0.039,
0.008).
mediation
was
0.005
(95%
[0.0004,
0.012],
OR:
1.005,
[1.000,
1.012]),
accounting
for
7.04%
total
effect.
subsequently,
we
examined
phenotypic
co-localization
two
pairings
independently,
revealing
that
posterior
probability
rs145516501
80.7%,
likelihood
rs4917820
95.9%.
indicated
seem
influence
causative
relationship
between
These
results
elucidate
complex
interplay
metabolism
context
offering
novel
diagnostic
therapeutic
avenues
enhancing
comprehension
disease's
etiology
prospective
research.
Language: Английский
Combining untargeted and targeted metabolomics to reveal the mechanisms of herb pair Anemarrhena asphodeloides Bunge and Phellodendron chinense C. K. Schneid on benign prostatic hyperplasia
Shuxuan Wang,
No information about this author
Caier Ju,
No information about this author
Mulan Chen
No information about this author
et al.
Journal of Ethnopharmacology,
Journal Year:
2024,
Volume and Issue:
334, P. 118539 - 118539
Published: Nov. 1, 2024
Language: Английский
Effects of Prostatic Inflammation on Clinical Outcomes in Patients with Benign Prostate Hyperplasia
Asad Mehmood,
No information about this author
Muhammad Mohsin Ayaz,
No information about this author
Majid Khan Kakakhel
No information about this author
et al.
Journal of Health and Rehabilitation Research,
Journal Year:
2024,
Volume and Issue:
4(1), P. 471 - 476
Published: Feb. 7, 2024
Background:
Benign
prostate
hyperplasia
(BPH),
a
non-cancerous
enlargement
of
the
gland,
prevalently
impacts
aging
male
population,
often
disrupting
quality
life
with
its
accompanying
urinary
symptoms.
The
intersection
between
BPH
and
prostatic
inflammation
has
emerged
as
focal
point
in
urological
research,
speculated
to
exacerbate
progression
Understanding
this
relationship
is
pivotal
refining
therapeutic
approaches
improving
patient
outcomes.
Objective:
This
study
aimed
elucidate
effects
on
clinical
outcomes
patients
BPH,
focusing
symptom
progression,
treatment
efficacy,
long-term
complications.
Methods:
Study
Conducted
at
Gajju
Khan
Medical
College
Swabi,
KPK,
Pakistan,
duration
from
January,
2023
June,
2023.
prospective
cohort
involved
126
men
categorized
into
two
groups
based
presence
(n=63)
or
absence
inflammation.
Data
were
collected
over
three
years,
assessments
including
demographic
information,
histories,
examinations.
Primary
measured
symptoms,
function,
size.
Secondary
included
life,
acute
retention,
need
for
surgical
intervention,
medication
Statistical
analyses
employed
Chi-square
tests,
t-tests,
ANOVA,
SPSS
software.
Results:
group
showed
significantly
more
severe
(p
<
0.01),
impaired
function
increased
size
0.01)
compared
non-inflamed
group.
also
favored
better
scores
(75.2
±
5.2
vs.
78.8
4.8,
p
lower
rates
retention
(20.3%
15.5%,
0.01).
Conclusion:
Prostatic
worsens
affecting
response,
likelihood
These
findings
suggest
integrated
strategies
that
address
both
optimize
care.
Language: Английский
Plasma metabolites as mediators in inflammation-related proteins - benign prostatic hyperplasia risk: insights from Mendelian randomization
Yan Cui,
No information about this author
Hui Wang,
No information about this author
Y Wang
No information about this author
et al.
Research Square (Research Square),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Aug. 14, 2024
Abstract
Benign
prostatic
hyperplasia
(BPH)
is
a
chronic
disease
that
pretends
to
occur
in
elderly
men.
Inflammatory
and
metabolic
factors
play
key
role
the
pathogenesis
progression
of
BPH.
The
extent
which
effects
91
inflammation-related
proteins
on
BPH
are
mediated
by
1400
plasma
metabolites
unclear.
In
our
study
we
examined
these
traits
using
genetic
evidence.
We
used
two-sample
Mendelian
randomization
(
MR)
Multivariable
MR
(MVMR)
determine:there
causal
relationship
between
Interleukin-2
levels
(IL-2)and
BPH,N6,N6-dimethyllysine
mediation
role:higher
IL-2
was
associated
with
higher
risk
BPH(β
=
0.071,
OR:1.074,95%CI[1.002–1.152],
p
0.045
lower
N6,N6-dimethyllysine
(β1=-0.127
p
0.02).The
(β2=-0.039,
p
0.008)
negatively
BPH.The
effect
0.005,95%
confidence
interval(CI)
[0.0004,0.012],odds-ratio
(OR)
:1.005,95%CI[1.000,1.012].Then,we
analyzed
phenotypic
co-localization
two
pairs
:
IL-2—BPH
levels—BPH,
showed
co-locate
SNP
rs145516501
NO.
13
chromosome.
levels,
co-located
rs4917820
10
chromosome.The
proportion
7.04%.The
suggested
appear
mediate
Language: Английский
Altered amino and fatty acids metabolism in Sudanese prostate cancer patients: insights from metabolic analysis
Journal of Circulating Biomarkers,
Journal Year:
2024,
Volume and Issue:
13(1), P. 36 - 44
Published: Dec. 16, 2024
Introduction:
Prostate
cancer
(PCa)
management
presents
a
multifaceted
clinical
challenge,
intricately
linking
oncological
considerations
with
cardiovascular
health.
Despite
the
recognized
importance
of
lipid
metabolism
and
hypertension
in
this
interwoven
relationship,
their
involvement
PCa
development
remains
partially
understood.
This
study
aimed
to
explore
variations
plasma
metabolome
among
Sudanese
patients
associated
comorbidities.
Methods:
Plasma
samples
were
collected
from
50
across
four
hospitals
Sudan
profiled
by
nuclear
magnetic
resonance
(NMR)
spectroscopy.
One-dimensional
proton
NMR
spectra
acquired
for
each
sample
using
standard
Overhauser
effect
spectroscopy
pulse
sequence
presat
on
500
MHz
Bruker
Avance
III
HD
spectrometer.
Metabolite
concentrations
quantified
R
scripts
developed
in-house.
Univariate
multivariate
analyses
generated
software.
Results:
Patients
categorized
into
distinct
metabotypes
based
metabolic
profiles,
statistical
conducted
evaluate
significance
observed
differences.
Our
findings
revealed
high
levels
fatty
acids,
phospholipids,
cholesterol,
valine,
leucine,
isoleucine
non-hypertensive
patients.
In
contrast,
hypertensive
GlycA
GlycB
altered
amino
acid
metabolism.
Conclusion:
These
underscore
intricate
interplay
between
dysregulation
Further
research
is
warranted
elucidate
precise
molecular
pathways
underlying
therapeutic
potential
targeting
these
pathways.
conclusion,
our
contributes
deeper
understanding
landscape
patients,
emphasizing
personalized
approaches
management.
Language: Английский